When does appetite suppression start with Mounjaro — and what to expect

The first injection: what actually happens in week one

Picture this: you've just done your first 2.5mg injection, and by day three you're wondering whether you've taken anything at all. That experience is completely normal, and far more common than the forums suggest. The 2.5mg pen exists specifically to let your digestive system acclimatise. For most people it produces mild GI effects (some nausea, perhaps a little bloating) rather than a dramatic drop in hunger. A handful of people do notice reduced appetite in that very first week, but for most, week one is about tolerability, not transformation.

What is happening biochemically, though, is real. Tirzepatide is already binding to GIP and GLP-1 receptors, slowing the rate at which your stomach empties and beginning to influence the brain signals that govern satiety. The NHS tirzepatide information page describes this dual receptor action as the foundation of how the medicine works. The full effect builds as the molecule reaches steady state in your bloodstream, which, with a once-weekly injection, takes a few weeks.

The honest acknowledgement here: if you've started and feel nothing, the wait is genuinely frustrating. Most people in that position aren't doing anything wrong.

Weeks five to twelve: when suppression tends to become reliable

The first dose increase, from 2.5mg to 5mg, typically happens around week five, subject to your prescriber's assessment. This is the moment many people describe as a switch flipping. Meals feel satisfying sooner, the urge to snack between them fades, and food simply occupies less mental space. Not everyone experiences it this dramatically, but a meaningful step-change in appetite around the first increase is consistent with how tirzepatide's pharmacology works: more receptor activation, stronger satiety signalling, a slower gastric empty.

For those who continue to 7.5mg and beyond, suppression tends to deepen further. The SURMOUNT-1 trial, which involved 2,539 adults over 72 weeks, found average weight reductions of around 20–21% at the 15mg maintenance dose, results that reflect sustained appetite reduction over many months rather than a brief early effect. You can read more about how and when tirzepatide begins working in our overview of when Mounjaro starts to work. The clinical picture across weeks five to twelve is generally progressive: each dose step tends to build on the last.

It is also worth noting that suppression is not the same as zero hunger. Most people still feel hungry, the change is that hunger becomes manageable rather than insistent. Understanding what suppression on Mounjaro actually means in practice helps set realistic expectations from the start.

Why the timeline differs between individuals

Two people on the same dose, injecting on the same day of the week, can have genuinely different experiences of when suppression kicks in. Several factors shape this. Gut hormone sensitivity varies; people with higher baseline GIP or GLP-1 resistance may notice a slower initial response. Body weight and composition affect distribution of the drug. And lifestyle factors (particularly protein intake and meal timing) interact with gastric emptying in ways that influence how suppressed appetite feels day to day.

There is also a psychological layer. People who have spent years overriding fullness cues sometimes find it takes a few weeks simply to recognise and trust the new signals. This is not a pharmacological failure; it is a recalibration. Our fuller discussion of Mounjaro and appetite suppression covers this in more detail, including what to do if you feel the effect wearing off between doses.

The timing question is also shaped by starting circumstances. Someone transferring from another GLP-1 treatment may notice suppression differently than someone starting fresh, and our guide to when to start Mounjaro covers how those starting circumstances can affect what you should expect in the early weeks. If you're still figuring out what your pattern looks like, the nume FAQ page, sorry, the nume FAQ page covers common questions about the first few weeks of treatment.

When to tell your prescriber, and what happens next

Absence of suppression at 2.5mg is expected. Absence at 5mg is worth monitoring. Absence at 7.5mg or above, persisting across a full four-week dosing period, is the point to raise it with your clinical team rather than simply increasing the dose yourself. Tirzepatide is a prescription-only medicine; dose adjustments happen through a prescriber, not through personal trial and error.

At nume, a real clinician reviews every repeat order before it is dispensed, the same-day clinical review means questions about appetite response, side effects and dose timing are part of the ongoing conversation rather than an afterthought. If you're weighing up what treatment might suit your circumstances, our treatment options page explains the full range we offer and how the consultation works. For those curious about the broader clinical profile of tirzepatide, the tirzepatide overview is a useful starting point.

Cost is a fair consideration at this stage too. Our guide to UK Mounjaro pricing sets out what happened to list prices in 2025 and what private treatment realistically costs, so you can plan without surprises.